These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32582979)

  • 1. Age‑related changes in mineralocorticoid receptors in rat hearts.
    Hu D; Dong R; Zhang Y; Yang Y; Chen Z; Tang Y; Fu M; Xu X; Tu L
    Mol Med Rep; 2020 Sep; 22(3):1859-1867. PubMed ID: 32582979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
    Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
    Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
    Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T
    J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the cardiac myocyte mineralocorticoid receptor ameliorates doxorubicin-induced cardiotoxicity.
    Lother A; Bergemann S; Kowalski J; Huck M; Gilsbach R; Bode C; Hein L
    Cardiovasc Res; 2018 Feb; 114(2):282-290. PubMed ID: 28430882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
    Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.
    Ayuzawa N; Nagase M; Ueda K; Nishimoto M; Kawarazaki W; Marumo T; Aiba A; Sakurai T; Shindo T; Fujita T
    Hypertension; 2016 Jan; 67(1):99-106. PubMed ID: 26527051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats.
    Yasuoka S; Kai H; Kajimoto H; Kudo H; Takayama N; Anegawa T; Koga M; Miyamoto T; Mifune H; Kage M; Hirooka Y; Imaizumi T
    Circ J; 2013; 77(6):1474-81. PubMed ID: 23470864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor blockade attenuates disrupted glutathione-dependent antioxidant defense and elevated endoglin in the hearts of pregnant rats exposed to testosterone.
    Usman TO; Badmus OO; Kim I; Olatunji LA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jul; 392(7):773-784. PubMed ID: 30783718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone's Antifibrotic Activity.
    Grune J; Beyhoff N; Smeir E; Chudek R; Blumrich A; Ban Z; Brix S; Betz IR; Schupp M; Foryst-Ludwig A; Klopfleisch R; Stawowy P; Houtman R; Kolkhof P; Kintscher U
    Hypertension; 2018 Apr; 71(4):599-608. PubMed ID: 29437893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central amygdala mineralocorticoid receptors modulate alcohol self-administration.
    Makhijani VH; Irukulapati P; Van Voorhies K; Fortino B; Besheer J
    Neuropharmacology; 2020 Dec; 181():108337. PubMed ID: 33007359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.
    Messaoudi S; Gravez B; Tarjus A; Pelloux V; Ouvrard-Pascaud A; Delcayre C; Samuel J; Launay JM; Sierra-Ramos C; Alvarez de la Rosa D; Clément K; Farman N; Jaisser F
    Hypertension; 2013 Feb; 61(2):361-7. PubMed ID: 23297371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined CaMKII inhibition and mineralocorticoid receptor antagonism via eplerenone inhibits functional deterioration in chronic pressure overloaded mice.
    Driessen HE; Fontes MS; van Stuijvenberg L; Brans MA; Goumans MJ; Vos MA; van Veen TA
    J Cell Mol Med; 2020 Aug; 24(15):8417-8429. PubMed ID: 32573944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
    Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
    Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.
    Wada T; Ishikawa A; Watanabe E; Nakamura Y; Aruga Y; Hasegawa H; Onogi Y; Honda H; Nagai Y; Takatsu K; Ishii Y; Sasahara M; Koya D; Tsuneki H; Sasaoka T
    J Endocrinol; 2017 Dec; 235(3):179-191. PubMed ID: 28855315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.